Patents by Inventor Janee M. Hardman

Janee M. Hardman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTINUOUS ENZYMATIC PERFUSION REACTOR SYSTEM
    Publication number: 20240058755
    Abstract: The present disclosure relates to methods, systems, and apparatus for efficient continuous production of hydrophobic products with the simultaneous retention of substrates.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 22, 2024
    Applicant: Graphium Biosciences, Inc.
    Inventors: Tyrel R. DEUTSCHER, Brandon J. ZIPP, Janee' M. HARDMAN
  • CANNABINOID GLYCOSIDES AND USES THEREOF
    Publication number: 20220227726
    Abstract: The present invention provides tetrahydrocannabinol glycoside and cannabidiol glycoside prodrugs and pharmaceutical compositions comprising these compounds, and their use for the site specific delivery of tetrahydrocannabinol or cannabidiol. Also provided are processes for the preparation of purified tetrahydrocannabinol glycoside and cannabidiol glycoside prodrugs.
    Type: Application
    Filed: October 26, 2021
    Publication date: July 21, 2022
    Applicant: Graphium Biosciences, Inc.
    Inventors: Janee' M. HARDMAN, Brandon J. ZIPP, Tyrel R. DEUTSCHER
  • CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS
    Publication number: 20220168428
    Abstract: The present invention relates to cannabinoid glycoside prodrugs suitable for site- and tissue-specific delivery of cannabinoid molecules. The present invention also relates to methods of forming the cannabinoid glycoside prodrugs through glycosyltransferase mediated glycosylation of cannabinoid molecules.
    Type: Application
    Filed: November 16, 2021
    Publication date: June 2, 2022
    Applicant: Graphium Biosciences, Inc.
    Inventors: Brandon J. Zipp, Janee M. Hardman, Robert T. Brooke
  • Cannabinoid glycoside prodrugs and methods of synthesis
    Patent number: 11207414
    Abstract: The present invention relates to cannabinoid glycoside prodrugs suitable for site- and tissue-specific delivery of cannabinoid molecules. The present invention also relates to methods of forming the cannabinoid glycoside prodrugs through glycosyltransferase mediated glycosylation of cannabinoid molecules.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: December 28, 2021
    Assignee: Graphium Biosciences, Inc.
    Inventors: Brandon J. Zipp, Janee M. Hardman, Robert T. Brooke
  • Cannabinoid Glycoside Prodrugs and Methods of Synthesis
    Publication number: 20180264122
    Abstract: The present invention relates to cannabinoid glycoside prodrugs suitable for site- and tissue-specific delivery of cannabinoid molecules. The present invention also relates to methods of forming the cannabinoid glycoside prodrugs through glycosyltransferase mediated glycosylation of cannabinoid molecules.
    Type: Application
    Filed: September 22, 2016
    Publication date: September 20, 2018
    Applicant: Vitality Biopharma, Inc.
    Inventors: Brandon J. Zipp, Janee M. Hardman, Robert T. Brooke